News Headlines Article

F.D.A Clears New Drug to Treat Colitis and Crohn’s
New York Times

United States health regulators on Tuesday approved a drug from Takeda Pharmaceutical of Japan to treat the chronic debilitating inflammatory diseases ulcerative colitis and Crohn’s disease.

The Food and Drug Administration said it had approved the drug, vedolizumab, which will be sold under the brand name Entyvio, for patients who failed to gain adequate relief from one or more current standard treatments.